相关实验视频

Updated: Jan 15, 2026

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on: October 17, 2025

在骨髓纤维化中使用imetelstat的结果:系统性审查和元分析

Moazzam Shahzad¹, Hafiz Muhammad Hannan Javed^2,3, Muhammad Shaheer Mannan⁴

¹Department of Hematology/Oncology, University of South Florida Morsani COM, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Leukemia & lymphoma

|October 15, 2025

概括

在治疗髓纤维化 (MF) 方面,Imetelstat通过逆转髓纤维化,显示出有前途. 这一元分析证实了其在抗JAK抑制剂的MF患者中的疗效,改善了存活率和减少纤维化.

科学领域:

血液学血液学血液学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

骨髓纤维化 (MF) 是一种严重的骨髓疾病.
逆转髓纤维化是MF的关键治疗目标之一.
目前,Imetelstat正在研究其在MF治疗中的潜力.

研究的目的:

评估Imetelstat在患有骨髓纤维化症的患者中的疗效.
评估结果,包括整体存活率和脏体积减少.
分析Imetelstat对骨髓纤维化的影响.

主要方法:

3项研究的元分析,包括197名多发性纤维患者.
对JAK2突变状态和之前的JAK抑制剂 (JAKi) 治疗数据的分析.
对整体存活率 (OS),体积减小 (SVR) 和骨髓纤维化减小 (BM) 的综合分析.

主要成果:

汇总的1年运行概率为80.95%.
对10%,20%和35%的聚合SVR率分别为22.40%,11.44%和4.42%.
在14.79%的患者中观察到BM纤维化1级以上的综合减少.

结论:

伊梅特尔斯塔特在MF患者中表现出有效性,这些患者已复发或对JAK抑制剂耐药.
伊梅特尔斯塔特显示出扭转髓纤维化和改善多发性肺炎患者的存活率的潜力.
对Imetelstat在MF管理中的作用进行进一步研究是有必要的.

关键词:

立即建立一个国家.雅克抑制剂的使用骨髓纤维化骨髓纤维化端粒酶抑制剂的使用

更多相关视频

In Vitro Stimulation and Visualization of Extracellular Trap Release in Differentiated Human Monocyte-derived Macrophages

In Vitro Stimulation and Visualization of Extracellular Trap Release in Differentiated Human Monocyte-derived Macrophages

Published on: November 1, 2019

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

Published on: September 16, 2019

相关概念视频

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...